Overview

Overview

Y-mAbs is committed to making a difference in pediatric oncology outcomes

Pediatric cancer has long been a challenge for the medical profession. With years of growing knowledge and insights, advancements are being made through research that may change protocols.

Y-mAbs is working to develop targeted approaches to treating rare and challenging pediatric cancers with the hope of extending survival and helping to address safety concerns. Some of the therapies we are researching are already in experimental clinical use at Memorial Sloan Kettering Cancer Center.

Clinical Trials

Y-mAbs is recruiting patients with high-risk neuroblastoma

Learn more